Background. Community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) reports are increasing, and infections often involve soft tissue. During a CO-MRSA skin infection outbreak in Alaska, we assessed risk factors for disease and whether a virulence factor, Panton-Valentine leukocidin (PVL), could account for the high rates of MRSA skin infection in this region.
(MRSA) has recently become an established cause of community infections (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In parts of the United States, MRSA accounts for the majority of community onset (CO) S. aureus infections (11, 14, 15] . CO-MRSA is most often associated with skin and soft tissue in fections rather than with invasive disease [ 1, 2, 8, 14, 16, 17] . CO-MRSA is commonly resistant only to {3-lactam antibiotics and typically demonstrates suscep tibility to trimethoprim-sulfamethoxazole, fluoroquin olones, and aminoglycosides (1, 4, 7, (11) (12) (13) (14) (15) (16) (17) . Previously published studies indicate that isolates causing CO MRSA infections are of a different genetic background, compared with hospital-acquired isolates from the same region (17) (18) (19) .
Risk factors for nosocomial MRSA are well estab lished and include prolonged antibiotic exposure, di alysis, and admission to an intensive care unit [20, 21] ,
